| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing azelaic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid adverse reaction |
Causative agent |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Allergy to azelaic acid |
Causative agent |
False |
Azelaic acid (substance) |
Inferred relationship |
Some |
|
| Azelaic acid 200 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelaic acid (substance) |
Inferred relationship |
Some |
|
| Azelaic acid 150 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelaic acid (substance) |
Inferred relationship |
Some |
|
| Allergy to azelaic acid |
Causative agent |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid 150 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid 150 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid 200 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid 200 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing azelaic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing only azelaic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
| Azelaic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelaic acid (substance) |
Inferred relationship |
Some |
1 |
FHIR